. E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. Am J Physiol Regulatory Integrative Comp Physiol 280: R1546-R1554, 2001.-In women, during pregnancy, there is decreased motility of the gastrointestinal tract leading to a delay in gastric emptying and an increase in colonic transit time. Whether the rise in estradiol (E2) or progesterone (P4) is responsible for this effect is controversial. As the nitrergic component of the nonadrenergic, noncholinergic (NANC) nerves is responsible for modulating gastrointestinal motility in vivo, the purpose of this study was to evaluate whether the increased release of nitric oxide (NO) from the nitrergic component of the NANC nerves innervating the gastric fundus and colon that occurs during late pregnancy in rats is mediated by E2 or P4. Ovariectomized rats treated with E 2 or P4 alone or in combination were used for our studies. We also wanted to assess the cellular and molecular mechanisms involved. The NANC activity was studied by assessing changes in tone after application of electric field stimulation (EFS). The role of NO was determined by observing the effects of EFS in the presence and absence of the NO synthase (NOS) inhibitor N G -nitro-L-arginine methyl ester (L-NAME) and the reversibility of the effects of L-NAME by L-arginine. Our studies indicated that there was increased magnitude of relaxation of isolated strips of rat gastric fundus and rat colon after application of EFS to tissues obtained from animals treated with E2 alone or a combination of E2 ϩ P4 but not from those treated with P 4 alone. L-NAME attenuated relaxation responses in E 2 -and E2 ϩ P4-treated animals. To elucidate whether the increased NO release may be due to an increase in neuronal NOS (nNOS) protein, we used both Western blot analysis and immunohistochemistry. We also used RT-PCR to determine whether there was an increase in nNOS mRNA after treatment with sex steroids. In nonpregnant animals, nNOS was detected by Western blot in the fundus and the colon and was barely detectable in the ileum. In pregnancy, there was an increase in nNOS in both the gastric fundus and the colon. The nNOS protein was also increased in ovariectomized animals treated with either E2 alone or E2 ϩ P4 but not P4 alone when compared with ovariectomized animals receiving vehicle. Our results indicated that there was an increase in nNOS protein that was localized to the neurons of the myenteric plexus in the gastric fundus and colon in E2-and E2 ϩ P 4-treated animals, but this increase was not observed in animals treated with P 4 alone. This increase in nNOS protein was accompanied by an increase in nNOS mRNA. These results suggest the possibility that E 2, rather than P4, may be responsible for the delay in gastric emptying and increase in colonic transit time observed in pregnancy. nitric oxide; estradiol; progesterone; nonadrenergic, noncholinergic nerves IN WOMEN, DURING PREGNANCY, there is decreased motility of the stomach (14, 18) leading to a delay in gastric emptying (10) as well as an increase in colonic transit time (12, 22) , but the exact mechanism by which this occurs is not known. Release of nitric oxide (NO) by neuronal NO synthase (nNOS) found in nonadrenergic, noncholinergic (NANC) neurons has been shown to be an important factor controlling gastrointestinal motility and transit time (2-6, 17). We have previously demonstrated an increase in the release of NO in the vascular compartment during late pregnancy (19). We subsequently also demonstrated an increased release of NO from the NANC nerves innervating the gastric fundus and proximal colon obtained from rats in late pregnancy compared with those obtained from nonpregnant animals or animals in midpregnancy. On this basis, we suggested that the delay in gastric emptying and increase in colonic transit time observed during late pregnancy might, in part, be due to increased activity of the nitrergic component of the NANC nerves innervating these organs (23).
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-nitro-L-arginine methyl ester (L-NAME) and the reversibility of the effects of L-NAME by L-arginine. Our studies indicated that there was increased magnitude of relaxation of isolated strips of rat gastric fundus and rat colon after application of EFS to tissues obtained from animals treated with E2 alone or a combination of E2 ϩ P4 but not from those treated with P 4 alone. L-NAME attenuated relaxation responses in E 2 -and E2 ϩ P4-treated animals. To elucidate whether the increased NO release may be due to an increase in neuronal NOS (nNOS) protein, we used both Western blot analysis and immunohistochemistry. We also used RT-PCR to determine whether there was an increase in nNOS mRNA after treatment with sex steroids. In nonpregnant animals, nNOS was detected by Western blot in the fundus and the colon and was barely detectable in the ileum. In pregnancy, there was an increase in nNOS in both the gastric fundus and the colon. The nNOS protein was also increased in ovariectomized animals treated with either E2 alone or E2 ϩ P4 but not P4 alone when compared with ovariectomized animals receiving vehicle. Our results indicated that there was an increase in nNOS protein that was localized to the neurons of the myenteric plexus in the gastric fundus and colon in E2-and E2 ϩ P 4-treated animals, but this increase was not observed in animals treated with P 4 alone. This increase in nNOS protein was accompanied by an increase in nNOS mRNA. These results suggest the possibility that E 2, rather than P4, may be responsible for the delay in gastric emptying and increase in colonic transit time observed in pregnancy. nitric oxide; estradiol; progesterone; nonadrenergic, noncholinergic nerves IN WOMEN, DURING PREGNANCY, there is decreased motility of the stomach (14, 18) leading to a delay in gastric emptying (10) as well as an increase in colonic transit time (12, 22) , but the exact mechanism by which this occurs is not known. Release of nitric oxide (NO) by neuronal NO synthase (nNOS) found in nonadrenergic, noncholinergic (NANC) neurons has been shown to be an important factor controlling gastrointestinal motility and transit time (2) (3) (4) (5) (6) 17) . We have previously demonstrated an increase in the release of NO in the vascular compartment during late pregnancy (19) . We subsequently also demonstrated an increased release of NO from the NANC nerves innervating the gastric fundus and proximal colon obtained from rats in late pregnancy compared with those obtained from nonpregnant animals or animals in midpregnancy. On this basis, we suggested that the delay in gastric emptying and increase in colonic transit time observed during late pregnancy might, in part, be due to increased activity of the nitrergic component of the NANC nerves innervating these organs (23) .
During pregnancy, there is an increase both in circulating estradiol (E 2 ) as well as progesterone (P 4 ) concentrations (16) . Therefore, we decided to assess whether both of these sex steroids could modulate NANC activity of the gastrointestinal tract and the potential mechanisms involved. Ovariectomized rats were treated with either E 2 or P 4 or a combination of both, after which the responses to electric field stimulation (EFS) of the isolated gastric fundus and colon were assessed. To elucidate whether the increased NO release may be due to an increase in nNOS protein, we used both Western blot analysis and immunohistochemical techniques. Furthermore, RT-PCR was used to determine whether there was an increase in nNOS mRNA after treatment with the sex steroids. The rat was chosen as the animal model as many of the gastrointestinal changes observed during pregnancy are similar to those observed in women (7, 8) . The NANC nerves have also been well characterized in this species, and increased release of NO occurs during EFS of strips of gastric fundus and colon obtained from this species during late pregnancy (23) .
MATERIAL AND METHODS

Animals
Virgin female and pregnant Sprague-Dawley rats (180-220 g, Harlan, Indianapolis, IN) were housed under conditions of controlled temperature and light cycle and were provided free access to food pellets and water. All animal experiments were performed after ethical approval was obtained from the Animal Research Committee of University of California at Los Angeles. Under anesthesia (pentobarbital sodium, 40 mg/kg ip), a laparotomy was performed, and in animals for certain groups, both the ovaries were removed. The abdominal incision was closed in layers. To assess the effects of E 2 and P4, the animals were divided into four groups. After ovariectomy, the animals in group 1 were injected with vehicle alone. Animals in group 2 were ovariectomized and then injected with E2 benzoate dissolved in corn oil at a dose of 100 g/kg sc for 12 days. Animals in group 3 were ovariectomized and then injected with corn oil alone subcutaneously for 6 days followed by subcutaneous injection of P 4 dissolved in corn oil (15 mg/kg) for the following 6 days. After ovariectomy, animals in group 4 received subcutaneous injection of E2 benzoate dissolved in corn oil at a concentration of 100 g/kg for 12 days, and P4 at a concentration of 15 mg/kg was administered subcutaneously to the animals simultaneously with E2 benzoate for the last 6 days of E2 therapy. The concentrations of E2 and P4 achieved using this protocol in preliminary experiments were 40 Ϯ 7 pg/ml and 190 Ϯ 9 ng/ml, respectively. These values correspond to those observed in rats during late pregnancy (16) . These doses of E 2 and P4 have also previously been shown to produce a delay in gastric emptying similar to that found in pregnancy (8) . The day after the administration of the last dose of steroid, animals were euthanized by intramuscular injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) followed by exsanguination. The abdomen was opened, and the fundus of the stomach, a segment of the ileum, and a segment of the ascending colon just proximal to the cecum were removed.
For studies on NANC activity, tissues were placed in Krebs bicarbonate solution (composition in mM: 118.0 NaCl, 4.7 KCl, 25.0 NaHCO 3, 1.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 11.5 glucose) gassed with a mixture of 95% O2 and 5% CO2. For studies on NOS, i.e., Western blotting and RT-PCR for nNOS, the tissues were frozen in liquid nitrogen and stored at Ϫ80°C. For studies on immunohistochemistry for nNOS, tissues were fixed in 10% formalin in PBS.
Chemicals
Acetylcholine chloride, phentolamine, propranolol, atropine, 5-hydroxytryptamine (5-HT), N -nitro-L-arginine methyl ester (L-NAME), triethanolamine hydrochloride (TEA-HCl), L-arginine-HCl, pepstatin, leupeptin, dithiothreitol, sodium acetate, Ponceau S solution, E 2 benzoate, progesterone, and tetrodotoxin were obtained from Sigma Chemical (St. Louis, MO). Diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA-NO) was obtained from Cayman Chemicals (Ann Arbor, MI). The antibody for nNOS (mouse monoclonal and polyclonal) were obtained from Transduction Laboratories (Louisville, KY). This antibody does not crossreact with either endothelial NOS or macrophage NOS. Hybond-polyvinylidene difluoride (PVDF) membrane, horseradish peroxidase-linked secondary antibody, and enhanced chemiluminescence (ECL) Western blotting kit were purchased from Amersham (Arlington Heights, IL). Tri-Reagent was purchased from Molecular Research Center (Cincinnati, OH). Gene AmpRNA PCR kit was obtained from PerkinElmer (Norwalk, CT). The primers used for RT-PCR (nNOS, gene accession number x59949) were obtained from Custom Primers (GIBCO-BRL, Gaithersburg, MD).
Studies After Application of EFS to Strips of Fundus, Ileum, and Colon
Studies with fundus. For preparation of the rat fundal strips (25) , the fundal portion of the stomach was dissected free, cut along the antimesenteric surface, and rinsed of any residual contents with Krebs buffer. Longitudinal strips (5 ϫ 10 mm) were cut and placed in a dish of clean Krebs. One side of a Tungsten wire triangle was woven through either narrow end of the tissue, and the tissues were suspended in a 25-ml, water-jacketed (37°C) organ bath containing Krebs bicarbonate solution gassed continuously with 95% O 2 and 5% CO2. The tissues were gradually stretched to a resting tension of 1 g (recorded with a Grass FTO3 force-displacement transducer attached either to a Soltec chart or recorder) and allowed to equilibrate for 30 min. The appropriate resting tension for fundal strips and segments of colon were determined in initial experiments as described by us previously (23) . Strips were placed under progressive increments of tension, and contractile responses to potassium chloride (120 mM in Krebs bicarbonate solution) were measured under the various resting tension conditions. Optimal length-tension relationships were achieved with resting tensions of 1 g for the fundal strips. Therefore, a resting tension of 1 g was applied to the tissues, and changes in tension were recorded with a Grass FTO3 force-displacement transducer attached to a Soltec chart recorder. Tissues were incubated with atropine (10 M), phentolamine (10 M), and propranolol (10 M) for 30 min to ensure blockade of adrenergic and cholinergic receptors. To observe relaxations, tone was raised 60-80% of maximal contraction produced by 120 mM KCl by addition of 5-HT to a final concentration of ϳ30 M. After maintenance of active tone for 30 min, EFS was performed with two parallel platinum electrodes connected to a current amplifier and a stimulator (Grass Instruments, SD9) at parameters of 0.5-ms pulse width and supramaximal voltage (40 V) during each 10-s train of stimulation throughout the experiment. On the basis of preliminary experiments, these parameters were selected after construction of frequencyresponse curves and at various voltages and then observing the absence of relaxation at the parameters used when EFS was applied in the presence of tetrodotoxin (1 M), which blocks nerve conductance by blocking the Na ϩ channel. Stimulation was delivered at varying frequencies (1, 2, 5, 10, 20, and 40 Hz), and the resulting changes in response were measured. The same protocol was repeated after the addition of either L-NAME (100 M) alone or in combination with L-arginine (1 mM).
Studies with colon. The colon was rinsed intralumenally with Krebs bicarbonate solution to remove any remaining contents. One side of a Tungsten triangle was inserted through the antimesenteric side of the colon at either end of the longitudinal segment and then suspended in a 25-ml, water-jacketed organ bath. The tissue was gradually stretched to a resting tension of 2 g recorded by a forcedisplacement transducer (as above) and allowed to equilibrate for 30 min. Tissues were incubated with atropine (10 M), phentolamine (10 M), and propranolol (10 M) for 30 min to block the adrenergic and cholinergic receptors. Two parallel platinum wire electrodes were positioned on either side of the tissue, and EFS was applied using the same parameters as stated above. It was difficult to maintain a consistent active tone of segments of colon with any available pharmacological agents except carbachol. In these tissues, application of EFS resulted in a quiescence of the intrinsic activity of the tissue. EFS was applied at varying frequencies (1, 5, 10, 15, 30 , and 45 Hz), and the responses were measured as a function of the length of time of quiescence (23) . This protocol was repeated in a similar manner after preincubation of the tissues with either L-NAME (100 M) alone or in combination with L-or D-arginine (1 mM). The sensitivity to NO of the fundus and colon was assessed using the NO donor DEA-NO as has been previously described (23) .
Western Blot Analysis for nNOS
Fundal, ileal, and colonic tissues were excised from virgin female rats and from rats from various groups of animals, i.e., ovariectomized rats, animals in late pregnancy (18-20 days) , and/or ovariectomized rats treated with E 2 alone, P4 alone, or with a combination of E2 and P4.
Fundal, ileal, and colonic tissues were excised from female rats. The tissues obtained from four animals in each of the various groups were homogenized in buffer A [20% (wt/vol); 50 mM TEA, pH 7.4, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM 1,4-dithiothreitol, 1.0 M pepstatin A, 2.0 M leupeptin, and 1.0 mM phenylmethylsulfonyl fluoride] on ice and then centrifuged at 20,000 g at 4°C for 1 h, and the supernatant of each sample was removed and analyzed for protein content using the Bio-Rad protein assay kit. The remaining samples were then diluted with Laemmli's loading buffer (50 mM Tris ⅐ HCl, pH 6.8, 14.3 mM ␤-mercaptoethanol, 2% SDS, 0.1% bromophenol blue) and boiled for 3 min. High molecular weight standard positive controls (150 g) and a volume of sample containing 150 g of protein were electrophoresed onto a 7.5% SDS-polyacrylamide gel and transferred to PVDF membrane using a semidry transfer apparatus. This concentration of protein was selected based on preliminary experiments wherein we loaded our positive controls and samples at different protein concentrations for fixed exposure times. This protein concentration gave a linear relationship between protein mass and optical densities. The PVDF membrane was incubated in blocking buffer [5% nonfat dry milk in PBS-Tween 20, 0.1% (vol/vol)] overnight at 4°C. The membrane was then washed three times for 10 min each in PBS-Tween 20 and incubated at room temperature with diluted (1:2,500) monoclonal nNOS antibody for 60 min. The membrane was washed again in PBS-Tween 20 for three times, 10 min each, and then incubated in diluted (1:1,000) secondary antibody for 60 min at room temperature. The membrane was washed three times for 15 min each in PBSTween 20. The presence of bound antibody on the membrane was determined using ECL-Western blot detection kit by exposing the membrane to autoradiography film (Hyperfilm-ECL, Amersham). The relative intensities were quantified by densitometric analysis.
RT-PCR
Tissues were harvested from animals in various treatment groups and frozen in liquid nitrogen. Total RNA (pooled from 4 animals in each of the treatment groups) from the frozen tissues was extracted using Tri-Reagent as described by the manufacturer's protocol (Molecular Research Center). Reverse transcription was performed with 4 g of total RNA, 50 units of Moloney murine leukemia RT, and 100 pmol of oligo(dT) and running the reaction at 42°C for 20 min as recommended by the manufacturer's protocol of the RT-PCR kit (Gene Amp RNA-PCR core kit from Perkin-Elmer). The resulting cDNA samples were PCR-amplified using the Gene Amp RNA-PCR kit and 100 ng each of sense and antisense primers. Five-hundred nanograms of RNA were used for GAPDH amplification. GAPDH was used as the housekeeping gene for comparison as this is not regulated by either E2 or P4 (20) . The following amplification cycle was used: initial denaturation at 94°C for 1 min, primer annealing at 60°C for 1 min, and extension at 72°C for 1.5 min for a total of 35 cycles. The following sets of primers were used: nNOS sense, 5Ј-GAATACCAGCCTGATCCATGGAA-3Ј; antisense, 5Ј-TC-CTCCAGGAGGGTGTCCACCGCATC-3Ј; GAPDH sense, 5Ј-GTGAAGGTCGGTGTCAACGGATTT-3Ј; antisense, 5Ј-CA-CAGTCTTCTGAGTGGCAGTGAT-3Ј (24) . The resulting PCR products were analyzed on a 1% agarose gel using appropriate molecular weight markers to verify the required size of the final PCR product. The identity of PCR products was confirmed by DNA sequencing (data not shown). The relative intensities of the bands were quantified by densitometric analysis (Personal Densitometer SI, Molecular Dynamics). The nNOS band was normalized to the GAPDH band, and the values were expressed as percent change from the control group (ovariectomized and vehicle only).
Immunohistochemistry
After animals were euthanized, tissue from the various groups was collected and fixed in 10% formalin in PBS. Whole tissues were embedded in paraffin, and sections of 3-5 m were cut and mounted on slides coated with poly-L-lysine. Slides were dried at 70°C for 10-15 min and rehydrated in distilled water. They were then placed in citrate buffer (10 mM, pH 6.0) and heated in an 800-W microwave oven at high power for 5 min (ϫ2), allowed to cool for at least 20 min in citrate buffer, and then washed in distilled water. Slides were placed in 1% H 2O2/methanol for 20 min and washed in running tap water for 2-3 min and then placed in PBS (pH 7.4). Either polyclonal nNOS antibody (dilution 1:20) was placed in normal goat serum for 20 min or monoclonal nNOS antibody (dilution 1:1,600) was placed in normal horse serum for 20 min. The horse or goat serum was decanted, and sections were covered in primary antibody, diluted in PBS, and incubated overnight at room temperature in a humidity chamber then washed with PBS. For polyclonal and monoclonal nNOS, slides were incubated in biotinylated antirabbit IgG for 30 min and biotinylated anti-mouse IgG for 45 min, respectively. The slides were incubated with antibody conjugated for 45 min followed by avidin-biotin complex for 30 min. The slides then were incubated in diaminobenzidine for 2-3 min, washed in running tap water for 2 min, stained with hematoxylin, washed in tap water, dehydrated, and mounted on slides as described previously (24) .
In each section, 10 fields were counted for negative, weakly positive, and strongly positive by an individual blinded to the treatment groups, and the mean obtained from at least three animals in each group was taken and displayed as percent positive neuronal cells.
Data Analysis
Values are expressed as mean Ϯ SE obtained from five to seven animals in each group except in experiments involving Western blotting and RT-PCR, in which four animals from each group were pooled for each experiment, and three such experiments were performed. For studies involving immunohistochemistry, three animals were used in each group. Values between groups were compared using two-way analysis of variance with Duncan's t-range or Student's t-test where appropriate.
RESULTS
Study 1
Studies following application of EFS to strips of fundus and colon. STUDIES WITH FUNDAL STRIP. Application of EFS resulted in a transient decrease in tone, and the magnitude of relaxation was frequency dependent. The relaxant response started at the time of application of EFS. The time taken for the tone to return to baseline correlated directly with the intensity and frequency of the stimulus. Figure 1 shows representative traces obtained following application of EFS to a fundal strip obtained from an ovariectomized animal and an animal treated with both E 2 and P 4 . Relaxant responses in tissues obtained from animals treated with E 2 ϩ P 4 or E 2 alone were of a similar magnitude and were significantly greater than those obtained from ovariectomized animals. The relaxant responses in tissues obtained from P 4 (alone)-treated animals were not significantly different from those obtained from ovariectomized animals (Fig. 2) . The role of NO was assessed by observing the magnitude of relaxation after application of EFS in the absence and presence of L-NAME alone (after incubation of tissue with L-NAME for at least 15 min) or in the presence of L-NAME and either L-or D-arginine. In the presence of L-NAME, there was attenuation of the relaxant responses, and this was significantly greater at lower frequencies in tissues obtained from animals treated with E 2 alone (data not shown) or E 2 and P 4 ( Fig. 3) , compared with ovariectomized controls. There was no significant difference observed in tissues obtained from P 4 -treated animals compared with controls (data not shown). L-but not D-arginine significantly reversed the effects of L-NAME (data not shown). Pretreatment with tetrodotoxin to the tissue bath for 30 min abolished all responses to EFS (data not shown).
STUDIES WITH COLON. Application of EFS resulted in a frequency-dependent inhibition of spontaneous rhythmicity, which remained for varying lengths of time depending on the magnitude of stimulation. The duration of this inhibitory effect after application of EFS greatly increased in tissues obtained from animals treated with E 2 ϩ P 4 or E 2 alone at frequencies of 10 Hz and above (Fig. 4) . There was no difference in the relaxant responses after EFS between P 4 -treated animals when compared with ovariectomized animals (data not shown). Prior incubation of the tissue with L-NAME resulted in an increase in basal spontaneous motility (data not shown) and a decrease in the duration of inhibitory response ( prior to L-NAME significantly reversed the responses observed with L-NAME alone (data not shown).
Study 2 Studies assessing magnitude of relaxant responses of strips of fundus and colon to DEA-NO, an NO donor.
In these experiments, the strips of fundus and colon were set up in isolated organ baths, and phentolamine (10 M), propronolol (10 M), and L-NAME were added to the oxygenated Krebs bicarbonate solution. Active tone was induced by carbachol (10 M). Concentration-response curves were generated using DEA-NO (10 Ϫ8 to 10 Ϫ4 M). The EC 50 values for the fundal strips and segment of colon obtained from non-hormone-treated animals were 60 Ϯ 15 and 45 Ϯ 8 M, respectively. The corresponding EC 50 values for the fundal strip and colon obtained from E 2 -treated animals were 68 Ϯ 11 and 53 Ϯ 9 M, respectively. Comparison of the EC 50 values to DEA-NO showed no significant difference between tissues obtained from E 2 -and vehicle-treated animals.
Study 3
Effect of pregnancy on nNOS protein in the gastrointestinal tract or treatment of ovariectomized animals with E 2 alone, P 4 alone, or E 2 ϩ P 4 on nNOS protein in rat colon using Western blot analysis. The Western blot analyses of nNOS of the gastric fundus, ileum, and colon from nonpregnant and pregnant animals are shown in Fig. 6 . In nonpregnant animals, nNOS was detected in the fundus and colon and was barely detectable in the ileum. In pregnancy, there was an Fig. 4 . Frequency-response curves assessing the lag phase after application of EFS (1-30 Hz, 10-s trains) to segments of rat colon obtained from OVX rats and OVX rats treated with either E2 alone or E2 and P4. Responses were measured as duration of decreased motility (expressed in seconds) after application of EFS. Each point represents mean value Ϯ SE from at least 6 different animals. *Significant difference from OVX controls (P Ͻ 0.05). increase of nNOS both in gastric fundus and in the colon. Western blot analyses of nNOS of colonic tissues from the various groups of animals are shown in Fig. 7 . Densitometric analysis showed that tissues from ovariectomized animals had significantly lower nNOS protein compared with those obtained from late-pregnant animals. There was also a greater increase in nNOS immunoreactivity in tissues obtained from E 2 -and E 2 ϩ P 4 -treated animals, whereas there was no change in nNOS in tissues obtained from animals treated with P 4 alone compared with those obtained from ovariectomized animals. Results from fundal tissue showed a similar trend (data not shown).
Study 4
Effect of pregnancy or treatment of ovariectomized animals with E 2 ϩ P 4 or E 2 or P 4 alone on immunohistochemical localization of nNOS in rat fundus and colon. nNOS-positive staining was observed in the myenteric plexus in the fundus and colon. This immunostaining was localized to the neurons and nerve fibers from these cells that formed a network in the circular and longitudinal smooth muscle layer. The surrounding Schwannian cells were not stained. Comparison of the fundus (Fig. 8) as well as the colon (Fig. 9 ) demonstrated an increase in the intensity of immunoreactivity for nNOS as well as an increase in the number of nNOS-positive cells in the myenteric plexus in animals in late pregnancy and those treated with either E 2 ( Figs. 8 and 9 ) or E 2 ϩ P 4 but not in animals treated with P 4 alone (data not shown) when compared with nonpregnant ovariectomized animals. The percentage of cells in the myenteric plexus that were negative, weakly positive, or strongly positive for nNOS in the rat colon from the various groups is indicated in Fig. 10 . The results in the fundus showed a similar trend to that observed in the colon (data not shown).
Study 5
Analysis of nNOS gene expression in the rat colon after exposure to sex steroids. In these studies, we assessed whether the increase in nNOS mRNA was responsible for the increase in nNOS protein during late pregnancy in the colon and whether this increase was modulated by E 2 and/or P 4 or both. Because levels of total RNA obtained were not sufficient to perform Northern blot analysis, RT-PCR was employed. Results indicated that there was an increase in nNOS mRNA in tissues obtained from animals in late pregnancy (42 Ϯ 8%) and those treated with either E 2 alone (35 Ϯ 7%) or E 2 ϩ P 4 (51 Ϯ 12%), but not P 4 alone (decrease of 12 Ϯ 8%), when compared with ovariectomized animals treated with vehicle alone (Fig. 11) .
DISCUSSION
The precise mechanism(s) responsible for the changes in gastrointestinal motility that occur during pregnancy is not known. It appears that sex steroids play an important role in modulating these effects as postmenopausal women being treated with sex hormone-replacement therapy had a decreased rate of gastric emptying of solids compared with men. In contrast, postmenopausal women without hormone replacement had rates of solid emptying similar to those of men (13) . Similarly, rats in diestrus had slower gastric emptying than ovariectomized rats (7) .
The precise sex steroid that is responsible for these changes is controversial. It has been suggested that P 4 may be responsible for this effect, because high concentrations of P 4 , when added to the tissue bath, could completely inhibit the spontaneous contractile activity of colonic smooth muscles in vitro (12, 15, 21, 22) . This inhibitory effect appeared to be specific for P 4 , because E 2 and corticosterone, when added to the tissue bath, were without effect. However, the concentration of P 4 required to produce this effect (M range) is much higher than the circulating concentration of P 4 (nM range) observed during pregnancy. On the other hand, other investigators have reported that parenteral administration of E 2 and P 4 simultaneously or E 2 alone to rats inhibited gastric emptying, whereas P 4 alone enhanced it (7). In another study, parenteral administration of relatively low doses of E 2 to male rats significantly delayed gastric emptying, whereas only very high doses of P 4 were required to produce this effect (8) . It therefore appears that the effects of P 4 in inhibiting colonic motility in vitro were only observed when P 4 was added to the tissue bath in supraphysiological concentrations, whereas E 2 and not P 4 inhibited gastrointestinal motility when administered systemically.
Irrespective of whether E 2 or P 4 is responsible for this effect, the mechanism by which they cause slowing of gastrointestinal motility is not known. The release of NO by NANC nerves has been shown to be an important factor controlling gut motility in vitro (2) (3) (4) (5) 17) as well as in vivo (6) , and this release is increased during pregnancy (23) . The primary objective of this study, therefore, was to assess whether E 2 and/or P 4 during pregnancy was responsible for the increased activity of the nitrergic component of the NANC nerves innervating the gastrointestinal tract. We also wanted to evaluate the cellular and molecular mechanisms that may be involved. The rat gastric fundus and rat colon were chosen for most of the studies as our previous studies indicated that there was an increase in the release of NO from the nitrergic component of the NANC nerves innervating the gastric fundus and colon of pregnant rats but not that of the ileum (23).
Our results indicate that after EFS, there was increased magnitude of relaxation of isolated strips of gastric fundus and colon of rats treated with either E 2 alone or E 2 and P 4 and was of a similar magnitude but not from those treated with P 4 alone. The relaxation after application of EFS was due to stimulation of the NANC nerves as the effects were observed in the presence of adrenergic and cholinergic receptor blockers, and the responses were abolished in the presence of tetrodotoxin. Similar to our previous studies (23) and those reported by others (2, 3, 5), we observed that application of EFS at low frequencies (1-20 Hz) to precontracted strips of gastric fundus relaxed the strips only during the period of transmural stimulation, and the tone returned to initial levels immediately after cessation of EFS, indicating the release of a mediator with a very short half-life such as NO. In contrast, EFS at higher frequencies (20 Hz and greater) induced relaxation that persisted for some time even after cessation of the stimulus. The relaxant responses at higher frequencies, because of the slow recovery, suggest that in addition to NO, another longacting mediator such as vasoactive intestinal peptide (VIP) (3) may also be involved. L-NAME, an inhibitor of NO synthesis, decreased the magnitude of relaxation, and this decrease was greater in tissues obtained from animals treated with either E 2 alone or E 2 and P 4 compared with control or P 4 -treated animals. As there was no difference in the sensitivity of the gastric fundus obtained from the different groups to DEA-NO, one can conclude that the effects observed in rats treated with either E 2 or a combination of E 2 and P 4 were most likely due to increased synthesis and release of NO from the NANC nerves.
Similarly, in studies with the proximal colon, the magnitude of relaxant effects after EFS and its inhibition after L-NAME was significantly greater in tissues obtained from E 2 -or E 2 and P 4 -treated animals but not those obtained from P 4 (only)-treated animals compared with controls. These studies, therefore, indicate that E 2 rather than P 4 was responsible for the increase in nitrergic activity.
We next assessed the cellular and molecular mechanisms by which E 2 increased the nitrergic activity similar to that observed in pregnancy. Our results indicated that the nNOS protein, as assessed by Western blot analysis, was increased in the gastric fundus and colon but not in the ileum in late pregnancy compared with nonpregnant controls. This finding correlated well with our previous study (23) in which we observed an increase in nitrergic activity during late pregnancy only in the gastric fundus and colon but not in the ileum. We also observed an increase in nNOS protein in the fundus and colon of animals treated with either E 2 alone or a combination of both E 2 and P 4 but not in animals treated with P 4 alone when compared with nonpregnant controls. This again correlated very well with the finding of other investigators (26, 27) , who showed an increase of nNOS with E 2 , and with our studies showing increased nitrergic activity in these groups of animals.
The increase in nNOS protein was mainly localized to the neurons in the myenteric plexus and the nerve axons coursing in parallel with the inner circular muscle. There were more nNOS-positive neurons in the colon compared with the fundus, and similar regional differences have also been reported by other investigators (1, 9, 11) . Analysis by immunohistochemistry revealed that parallel with changes in the intensity of nNOS staining, the number of detectable nNOS-positive cells was also increased during late pregnancy and after treatment with a combination of E 2 and P 4 or E 2 alone but not with P 4 alone. These data suggest that in addition to the possibility that E 2 stimulates individual neurons to produce more nNOS, they are consistent with the interpretation that E 2 alone, or a combination of E 2 and P 4 , causes the recruitment of additional neurons to the active nNOS pool.
This increase in nNOS protein may have been due to increased gene expression or to an increase in mRNA stability mediated by E 2 . The increase in nNOS protein by E 2 may also have been due to increased translation or posttranslational stability, although these aspects were not assessed in this study. Our results are similar to those of other investigators who also observed an increase in the expression of nNOS in the gastrointestinal tract during pregnancy and after E 2 (26, 27) . There is no estrogen-responsive element in the promoter region for nNOS gene and the mechanism by which E 2 increased nNOS gene expression or the type of estrogen receptor involved was not assessed in this study, and this is the subject for future studies.
Although our studies specifically focused on the role of E 2 and P 4 in modulating the nitrergic component of the NANC nerves, we have not ruled out the possibility that increased release of other inhibitory mediators like VIP from the NANC nerves may also modulate gastrointestinal activity during pregnancy. Our studies, therefore, support the concept that increased nitrergic activity of the NANC nerves may, at least in part, be responsible for the decrease in motility of the gastric fundus and colon during pregnancy. Our studies also suggest the possibility that this effect is most likely mediated by E 2 and not by P 4 . Further studies are needed to assess whether physiological concentrations of P 4 also cause a decrease in gastrointestinal motility by other mechanisms.
Perspectives
Increased release of NO from NANC nerves innervating the gastric fundus is modulated by E 2 . This may be a potential explanation for many of the gastrointestinal changes such as esophageal reflux, delayed gastric emptying, and constipation experienced by women during pregnancy.
